ID: ALA258938

Max Phase: Preclinical

Molecular Formula: C16H14N2O5

Molecular Weight: 314.30

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  O=C(Nc1ccc([N+](=O)[O-])cc1)C1C(=O)C2=C(CCCC2)C1=O

Standard InChI:  InChI=1S/C16H14N2O5/c19-14-11-3-1-2-4-12(11)15(20)13(14)16(21)17-9-5-7-10(8-6-9)18(22)23/h5-8,13H,1-4H2,(H,17,21)

Standard InChI Key:  ULDBILQQZDKBPX-UHFFFAOYSA-N

Associated Targets(Human)

Voltage-gated potassium channel subfamily A member 1/beta-1 22 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Voltage-gated potassium channel subunit Kv1.1 248 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Potassium voltage-gated channel subfamily D member 2 12 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Mus musculus 284745 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 314.30Molecular Weight (Monoisotopic): 314.0903AlogP: 2.17#Rotatable Bonds: 3
Polar Surface Area: 106.38Molecular Species: ACIDHBA: 5HBD: 1
#RO5 Violations: 0HBA (Lipinski): 7HBD (Lipinski): 1#RO5 Violations (Lipinski): 0
CX Acidic pKa: 4.50CX Basic pKa: CX LogP: 3.06CX LogD: 1.02
Aromatic Rings: 1Heavy Atoms: 23QED Weighted: 0.52Np Likeness Score: -0.90

References

1. Lu Q, Peevey J, Jow F, Monaghan MM, Mendoza G, Zhang H, Wu J, Kim CY, Bicksler J, Greenblatt L, Lin SS, Childers W, Bowlby MR..  (2008)  Disruption of Kv1.1 N-type inactivation by novel small molecule inhibitors (disinactivators).,  16  (6): [PMID:18226531] [10.1016/j.bmc.2007.12.031]

Source